Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabiola Atzeni

Showing results (111-120 of 395) with videos related to

Pageof 40
Sort By:
Journal of Clinical Medicine|August 12, 2023
Metabolic Syndrome and Its Components Have a Different Presentation and Impact as Cardiovascular Risk Factors in Psoriatic and Rheumatoid ArthritisFabiola Atzeni, Laura La Corte, Mariateresa Cirillo, et al.
Pain and Therapy|March 16, 2021
Pain in Women: A Perspective Review on a Relevant Clinical Issue that Deserves PrioritizationRoberto Casale, Fabiola Atzeni, Laura Bazzichi, et al.
Rheumatology International|February 11, 2014
Fibromyalgia in patients with axial spondyloarthritis: epidemiological profile and effect on measures of disease activityFausto Salaffi, Rossella De Angelis, Marina Carotti, et al.
Clinical and Experimental Rheumatology|December 31, 2013
Fibromyalgia: a critical digest of the recent literatureCamillo Giacomelli, Francesca Sernissi, Piercarlo Sarzi-Puttini, et al.
Autoimmunity Reviews|November 8, 2017
Are the ACR 2010 diagnostic criteria for fibromyalgia better than the 1990 criteria?Piercarlo Sarzi-Puttini, Fabiola Atzeni, Ignazio Francesco Masala, et al.
The Journal of Rheumatology|July 5, 2005
Sex hormone concentrations in patients with rheumatoid arthritis are not normalized during 12 weeks of anti-tumor necrosis factor therapyRainer H Straub, Peter Härle, Fabiola Atzeni, et al.
Expert Review of Clinical Pharmacology|September 17, 2016
What are the dangers of biological therapy discontinuation or dose reduction strategies when treating rheumatoid arthritis?Fabiola Atzeni, Maurizio Benucci, Rossella Talotta, et al.
Best Practice & Research. Clinical Rheumatology|November 19, 2011
Chronic widespread pain in the spectrum of rheumatological diseasesFabiola Atzeni, Marco Cazzola, Maurizio Benucci, et al.
Acta Bio-Medica : Atenei Parmensis|September 6, 2021
Rheumatoid Arthritis disease activity assessment in routine care: performance of the most widely used composite disease activity indices and patient-reported outcome measuresFausto Salaffi, Marco Di Carlo, Sonia Farah, et al.
Journal of Clinical Medicine|February 4, 2021
The Key Comorbidities in Patients with Rheumatoid Arthritis: A Narrative ReviewPeter C Taylor, Fabiola Atzeni, Alejandro Balsa, et al.
Pageof 40

Showing results (111-120 of 395) with videos related to

Sort By:
Pageof 40
Journal of Clinical Medicine|August 12, 2023
Metabolic Syndrome and Its Components Have a Different Presentation and Impact as Cardiovascular Risk Factors in Psoriatic and Rheumatoid ArthritisFabiola Atzeni, Laura La Corte, Mariateresa Cirillo, et al.
Pain and Therapy|March 16, 2021
Pain in Women: A Perspective Review on a Relevant Clinical Issue that Deserves PrioritizationRoberto Casale, Fabiola Atzeni, Laura Bazzichi, et al.
Rheumatology International|February 11, 2014
Fibromyalgia in patients with axial spondyloarthritis: epidemiological profile and effect on measures of disease activityFausto Salaffi, Rossella De Angelis, Marina Carotti, et al.
Clinical and Experimental Rheumatology|December 31, 2013
Fibromyalgia: a critical digest of the recent literatureCamillo Giacomelli, Francesca Sernissi, Piercarlo Sarzi-Puttini, et al.
Autoimmunity Reviews|November 8, 2017
Are the ACR 2010 diagnostic criteria for fibromyalgia better than the 1990 criteria?Piercarlo Sarzi-Puttini, Fabiola Atzeni, Ignazio Francesco Masala, et al.
The Journal of Rheumatology|July 5, 2005
Sex hormone concentrations in patients with rheumatoid arthritis are not normalized during 12 weeks of anti-tumor necrosis factor therapyRainer H Straub, Peter Härle, Fabiola Atzeni, et al.
Expert Review of Clinical Pharmacology|September 17, 2016
What are the dangers of biological therapy discontinuation or dose reduction strategies when treating rheumatoid arthritis?Fabiola Atzeni, Maurizio Benucci, Rossella Talotta, et al.
Best Practice & Research. Clinical Rheumatology|November 19, 2011
Chronic widespread pain in the spectrum of rheumatological diseasesFabiola Atzeni, Marco Cazzola, Maurizio Benucci, et al.
Acta Bio-Medica : Atenei Parmensis|September 6, 2021
Rheumatoid Arthritis disease activity assessment in routine care: performance of the most widely used composite disease activity indices and patient-reported outcome measuresFausto Salaffi, Marco Di Carlo, Sonia Farah, et al.
Journal of Clinical Medicine|February 4, 2021
The Key Comorbidities in Patients with Rheumatoid Arthritis: A Narrative ReviewPeter C Taylor, Fabiola Atzeni, Alejandro Balsa, et al.
Pageof 40